1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology
(
- Contribution to journal › Article
-
Mark
Self-Report Tool for Identification of Individuals With Coronary Atherosclerosis : The Swedish CardioPulmonary BioImage Study
(
- Contribution to journal › Article
- 2023
-
Mark
Age and sex differences in cause-specific excess mortality and years of life lost associated with COVID-19 infection in the Swedish population
(
- Contribution to journal › Article
-
Mark
Pulmonary embolism and deep venous thrombosis after COVID-19 : long-term risk in a population-based cohort study
(
- Contribution to journal › Article
- 2022
-
Mark
Severe COVID-19 in people 55 and older during the first year of the pandemic in Sweden
(
- Contribution to journal › Article
-
Mark
COVID-19 in people aged 18–64 in Sweden in the first year of the pandemic : Key factors for severe disease and death
(
- Contribution to journal › Article
- 2021
-
Mark
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
(
- Contribution to journal › Article
- 2015
-
Mark
Imaging of Intracellular and Extracellular ROS Levels in Atherosclerotic Mouse Aortas Ex Vivo: Effects of Lipid Lowering by Diet or Atorvastatin.
(
- Contribution to journal › Article
- 2013
-
Mark
Genetic Variation in SULF2 Is Associated with Postprandial Clearance of Triglyceride-Rich Remnant Particles and Triglyceride Levels in Healthy Subjects
(
- Contribution to journal › Article
- 2012
-
Mark
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
(
- Contribution to journal › Article